Resource Centre
10 results
Detecting, classifying, and monitoring CNS tumors with nanopore sequencing
- cfDNA
- Cancer research
- Neuroscience
- Methylation
July 14 2023
Same-day, multiplexed, high-accuracy targeted liquid biopsy approach for low-tumor content treatment response monitoring
- cfDNA
- Bioinformatics
- Cancer research
- SNVs
- Targeted
- London Calling
May 19 2023
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing
- cfDNA
- Cancer research
- MinION
November 9 2023
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
- cfDNA
- Human genomics
- Clinical research
- Cancer research
- Oncology
- DNA
- gDNA
- Real-time
- Structural variation
- Whole genome
- Variant calling
- GridION
February 12 2021
Nanopore sequencing from liquid biopsy: analysis of copy number variants from cell-free DNA of lung cancer patients
- cfDNA
- Cancer research
- Clinical research
February 12 2021
Nanopore-based consensus sequencing enables accurate multimodal tumour cell-free DNA profiling
- cfDNA
- Cancer research
- SNVs
February 17 2024
Long-read sequencing reveals aberrant fragmentation patterns and origins of circulating DNA in cancer
- cfDNA
- Cancer research
- Whole genome
May 5 2024
Glioblastoma, IDH-wildtype with primarily leptomeningeal localisation diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid
- cfDNA
- Cancer research
- Methylation
September 3 2024
Classification of brain tumors by nanopore sequencing of cell-free DNA from cerebrospinal fluid
- cfDNA
- Cancer research
- Clinical research
- MinION
August 25 2023
Accurate detection of circulating tumor DNA using nanopore consensus sequencing
- cfDNA
- Clinical research
- Cancer research
- Oncology
- Human genomics
- DNA
- Variant calling
- Amplicons
- MinION
- Flongle
December 9 2021